Clinical Trial Results TV
October 25, 2012: Dr. Julinda Mehilli and Dr. C. Michael Gibson discuss: ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-E
Dr. Julinda Mehilli and Dr. C. Michael Gibson discuss: ISAR-LEFT MAIN 2: A Prospective,
Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with
Unprotected Left Main Disease.

Within the past 12 months, I or my spouse/partner have had a financial
interest/arrangement or affiliation with the organization(s) listed below.

Lecture fees:

Abbott Vascular
Daichii Sankyo/Lilly
The Medicines
Terumo

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
05-26-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted